z-logo
open-access-imgOpen Access
Characteristics of hypertension in obstructive sleep apnea: An Asian experience
Author(s) -
Hoshide Satoshi,
Kario Kazuomi,
Chia YookChin,
Siddique Saulat,
Buranakitjaroen Peera,
Tsoi Kelvin,
Tay Jam Chin,
Turana Yuda,
Chen ChenHuan,
Cheng HaoMin,
Huynh Van Minh,
Park Sungha,
Soenarta Arieska Ann,
Sogunuru Guru Prasad,
Wang TzungDau,
Wang JiGuang
Publication year - 2021
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.14184
Subject(s) - medicine , arterial stiffness , obstructive sleep apnea , ambulatory blood pressure , cardiology , morning , blood pressure , sleep apnea , population , dipper , environmental health
Obstructive sleep apnea (OSA) is a risk of hypertension and is associated with cardiovascular disease (CVD) incidence. In Asian countries, the prevalence of OSA is high, as in Western countries. When blood pressure (BP) is evaluated in OSA individuals using ambulatory BP monitoring (ABPM), the BP phenotype often indicates abnormal BP variability, such as increased nighttime BP or abnormal diurnal BP variation, that is, non‐dipper pattern, riser pattern, and morning BP surge, and all these conditions have been associated with increased CVD events. Asians have a higher prevalence of increased nighttime BP or morning BP surge than Westerners. Therefore, this review paper focused on OSA and hypertension from an Asian perspective to investigate the importance of the association between OSA and hypertension in the Asian population. Such abnormal BP variability has been shown to be associated with progression of arterial stiffness, and this association could provoke a vicious cycle between abnormal BP phenotypes and arterial stiffness, a phenomenon recognized as systemic hemodynamic atherothrombotic syndrome (SHATS). OSA may be one of the background factors that augment SHATS. An oxygen‐triggered nocturnal oscillometric BP measurement device combined with a pulse oximeter for continuous SpO 2 monitoring could detect BP variability caused by OSA. In addition to treating the OSA, accurate and reliable detection and treatment of any residual BP elevation and BP variability caused by OSA would be necessary to prevent CVD events. However, more detailed detection of BP variability, such as beat‐by‐beat BP monitoring, would further help to reduce CV events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here